Diverticulitis: Clinical Trials

9 trials for Diverticulitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting, 1 terminated, 1 unknown. 9 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 6, Recruiting 1, Terminated 1, Unknown 1
Phase 33Completed 2, Terminated 1
Phase 11Completed 1

Follow Diverticulitis: new trials by email Literature Review of Diverticulitis trials Research Report on Diverticulitis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis
MBK-01 - Diverticulitis, Diverticulitis of Sigmoid
Phase 2RecruitingMikrobiomik Healthcare Company S.L.812025-04-032025-06-05
Combination of Curcumin and Berberine Therapy in the Treatment of Post Acute Diverticulitis (SUDD)
Curcumin-Berberine (coptis), Placebo - Diverticulitis
Phase 2UnknownDr. Adi Lahat402022-08-142023-12-08
Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications.
Rifaximin delayed released 400mg Tablet, Placebo - Diverticulitis
Phase 2 / Phase 3TerminatedAlfasigma S.p.A.1932018-07-022021-10-20
Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program
Spinal analgesia, Patient Control Analgesia (PCA) Morphine - Colon Cancer, Inflammatory Bowel Diseases
Phase 1 / Phase 2CompletedMcGill University Health Centre/Research Institute of the McGill University Health Centre402010-10-012011-11-28
Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine
Lidocaine, Thoracic epidural block - Colon Cancer, Inflammatory Bowel Diseases
Phase 2CompletedMcGill University Health Centre/Research Institute of the McGill University Health Centre602009-06-012011-11-28
Asacol Acute Diverticulitis(DIVA)Study
Mesalamine, Probiotic, Placebo - Diverticulitis
Phase 2CompletedWarner Chilcott1172007-11-012013-04-22
Hartmann's Versus Primary Anastomosis in Left-sided Colon Perforation
Hartmann's operation, Primary anastomosis - Surgery, Diverticulitis
Phase 2 / Phase 3CompletedUniversity of Zurich622006-05-012012-05-28
Hartmann vs R/A in Peritonitis by Perforated Diverticulitis
Primary sigmoid resection with end colostomy (Hartmann), Primary sigmoid resection and immediate anastomosis with diverting stoma (PRA) - Peritonitis Caused by Perforated Left-sided Colon Diverticulitis
Phase 2 / Phase 3CompletedEnte Ospedaliero Ospedali Galliera1002000-01-012010-11-15
End-to-End Compression Anastomosis for Left-sided Colectomy Endo-CAR Study
Niti CAR - Colorectal Cancer, Diverticulitis
Phase 2CompletedNiti Medical Technologies Ltd.2011-06-29

Narrower conditions

Colonic Neoplasms (2)  ·  Inflammatory Bowel Diseases (2)  ·  Colorectal Neoplasms (1)  ·  Diverticular Diseases (1)  ·  Diverticulum (1)  ·  Intestinal Perforation (1)  ·  Neoplasms (1)  ·  Postoperative Complications (1)

Broader conditions

Digestive System Diseases (9)  ·  Gastroenteritis (9)  ·  Gastrointestinal Diseases (9)  ·  Diverticular Diseases (8)  ·  Intestinal Diseases (4)  ·  Colonic Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Gastrointestinal Neoplasms (3)  ·  Intestinal Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Colorectal Neoplasms (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Anatomical (1)

Interventions

Anesthesia, Spinal (1)  ·  Anti-Bacterial Agents (1)  ·  Colectomy (1)  ·  Coptis extract (1)  ·  Fecal Microbiota Transplantation (1)  ·  Lidocaine (1)  ·  Mesalamine (1)  ·  Morphine (1)  ·  Nutrition Assessment (1)  ·  Passive Cutaneous Anaphylaxis (1)  ·  Probiotics (1)  ·  Tablets (1)  ·  Tea (1)

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre (2)  ·  Alfasigma S.p.A. (1)  ·  Dr. Adi Lahat (1)  ·  Ente Ospedaliero Ospedali Galliera (1)  ·  Mikrobiomik Healthcare Company S.L. (1)  ·  Niti Medical Technologies Ltd. (1)  ·  University of Zurich (1)  ·  Warner Chilcott (1)

Countries

Canada (2)  ·  Italy (2)  ·  Spain (2)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Adi Lahat-Zok, MD (1)  ·  Alberto Serventi (1)  ·  Ana Balske, MD, PhD (1)  ·  Franco Carli, Professor (1)  ·  Gian Andrea Binda (1)  ·  Mingkwan Wongyingsinn, Fellow (1)  ·  Roberto Bergamaschi, MD (1)  ·  Stefan Breitenstein, MD (1)

Results publications

PMID 21519309, PMID 23095627, PMID 23426454

NIH funding

2017 (1), 2023 (1)